GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient, and cancer-care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network. GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-ray machines in the next three years. It also includes a six-year service contract.
In addition, Affidea expands its collaboration with GE Healthcare in pharmaceutical diagnostics in all its geographies, to include Clariscan, GE Healthcare’s new contrast-media product, used in MRI exams. With this partnership agreement, Affidea and GE Healthcare aim to complete the activation of Affidea’s fleet of imaging equipment as a data-driven, connected, and networked functionality, to enable clinicians’ collaboration, enhance sub-specialization, and support business leaders to measurably improve operations near real time.
Affidea will deploy PACS (picture archiving and communication system)-driven post-processing hubs, with the latest technologies and performance analytics capabilities with imaging insights, using GE Healthcare’s Edison intelligence platform at scale. GE Healthcare and Affidea will also combine their respective clinical education, lean and leadership development expertise using digital technologies to accelerate best practice adoption.